OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business HighlightsBusiness Wire • 03/04/26
OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform TranscriptSeeking Alpha • 12/16/25
Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery TechnologiesBusiness Wire • 12/15/25
OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global InvestorsBusiness Wire • 11/17/25
OmniAb, Inc. (OABI) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 10/28/25
OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment ConferenceBusiness Wire • 09/02/25
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston SummitBusiness Wire • 05/13/25